Edition:
India

People: Jaguar Health Inc (JAGX.OQ)

JAGX.OQ on NASDAQ Stock Exchange Capital Market

1.63USD
1:30am IST
Change (% chg)

$0.03 (+1.88%)
Prev Close
$1.60
Open
$1.61
Day's High
$1.63
Day's Low
$1.55
Volume
51,325
Avg. Vol
89,983
52-wk High
$14.85
52-wk Low
$1.55

Kamphuis, Folkert 

Mr. Folkert W. Kamphuis is the Director of the Company. Mr. Kamphuis currently has his own consulting business. He most recently served as Global Head of Strategic Planning at Novartis Animal Health, the former animal health unit of Swiss pharmaceutical giant Novartis, a role in which he oversaw business development and licensing, portfolio and salesforce development, and was a member of Novartis’s Animal Health Executive Committee, until its acquisition by Elanco. Mr Kamphuis joined Novartis Animal Health in 2009, and from 2012 to 2014 served as General Manager North America and as Chief Operating Officer from 2009 to 2012. Prior thereto, Mr. Kamphuis spent 20 years in various executive, business development and global marketing roles at Pfizer Animal Health/Pharmacia and Merial/Merck Sharp & Dohme in different roles. Mr. Kamphuis received a B.A. in Marketing equivalent degree (VWO-b) from the Dutch Institute of Marketing, Drachten, the Netherlands, and an MSc in Animal Nutrition from the Wageningen University and Research Center, Wageningen, the Netherlands. Mr. Kamphuis’ extensive experience and education in the animal health sector led the Board to conclude that he is qualified to serve as a director of the Company.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --